Latest News & Updates

Breaking News

3 hours ago
Pharma Now Editorial Team

Oral Semaglutide Clears Pediatric Bar, Raising Scale-Up Questions

Clariant Expands Desiccant Reel Output to Cut Lead Times in Americas

Pharma Now Editorial Team

EMA Scientific Advice Locks In CLINUVEL Phase III Vitiligo Design

Pharma Now Editorial Team

Dual-Vector AAV Approval in 61 Days Resets BLA Expectations

Pharma Now Editorial Team

Single Phase 3 Trial Secures FDA Approval for Novel Gonorrhea Antibiotic

Pharma Now Editorial Team

Other trending news you may like to read

Oral Semaglutide Clears Pediatric Bar, Raising Scale-Up Questions

Novo Nordisk's oral semaglutide shows superior HbA1c reduction in pediatric type 2 diabetes, signaling new manufacturing and regulatory demands.

Pharma Now Editorial Team

Clariant Expands Desiccant Reel Output to Cut Lead Times in Americas

Clariant expands desiccant reel production in the Americas to cut lead times and inventory complexity for pharma and nutraceutical packagers.

Pharma Now Editorial Team

EMA Scientific Advice Locks In CLINUVEL Phase III Vitiligo Design

CLINUVEL secures final EMA scientific advice for its pivotal Phase III vitiligo trial, locking in regulatory design parameters ahead of study commencement.

Pharma Now Editorial Team

Dual-Vector AAV Approval in 61 Days Resets BLA Expectations

Regeneron's Otarmeni cleared in 61 days under CNPV, the first gene therapy approved via the pilot and a benchmark for dual-vector AAV regulatory strategy.

Pharma Now Editorial Team